| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 21, 2025 | May 22, 2025 | Prime Medicine, Inc. | CEO | Buy | 95.0 | +125,000 | 100.00% | ✗ | $147.2K |
| Aug 16, 2017 | Aug 17, 2017 | PALVELLA THERAPEUTICS, INC. | Officer | Buy | 97.5 | +65,000 | 100.00% | ✗ | $313.4K |